Is There a Place for Cardiovascular Magnetic Resonance Imaging in the Evaluation of Cardiovascular Involvement in Rheumatic Diseases?

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 3, 2011, Pages 488-496

  Mavrogeni, Sophie ^a   Vassilopoulos, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cardiovascular magnetic resonance imaging; Rheumatic diseases

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CHURG STRAUSS SYNDROME; CONTRAST ENHANCEMENT; CORONARY ARTERY ANOMALY; DRUG SAFETY; ECHOCARDIOGRAPHY; GOLD STANDARD; HEART EDEMA; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FUNCTION; HEART VENTRICLE VOLUME; HEART VENTRICLE WALL MOTION; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; IRON OVERLOAD; LATE GADOLINIUM ENHANCED IMAGE; MAGNETIC RESONANCE ANGIOGRAPHY; MYOCARDIAL EDEMA; MYOCARDIAL PERFUSION IMAGING; MYOCARDITIS; NEPHROGENIC SYSTEMIC FIBROSIS; NEPHROTOXICITY; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VASCULITIS;

CARDIOVASCULAR DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; RHEUMATIC DISEASES;

EID: 82955249088     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.04.004     Document Type: Review

References (86)

1. Diethelm L., Dery R., Lipton M.J., Higgins C.B. Atrial-level shunts: sensitivity and specificity of MR in diagnosis. Radiology 1987, 162:181-186.
2. Mavrogeni S.I., Markussis V., Kaklamanis L., Tsiapras D., Paraskevaidis I., Karavolias G., et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with [beta]-thalassemia major. Eur J Haematol 2005, 75:241-247.
3. Wagner S., Auffermann W., Buser P., Lim T.H., Kircher B., Pflugfelder P., et al. Diagnostic accuracy and estimation of the severity of valvular regurgitation from the signal void on cine magnetic resonance imaging. Am Heart J 1989, 118:760-767.
4. Masui T., Finck S., Higgins C.B. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992, 182:369-373.
5. Nienaber C.A., von Kodolitsch Y., Nicholas V., Siglow V., Piepho A., Brockhoff C., et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med 1993, 328:1-9.
6. Kim W.Y., Danias P.G., Stuber M., Flamm S.D., Plein S., Nagel E., et al. Coronary magnetic resonance angiography for the detection of coronary stenosis. N Engl J Med 2001, 345:1863-1869.
7. Manning W.J., Li W., Edelman R.R. A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med 1993, 328:828-832.
8. Post J.C., van Rossum A.C., Bronzwaer J.G., de Cock C.C., Hofman M.B., Valk J., et al. Magnetic resonance angiography of anomalous coronary arteries: a new gold standard for delineating the proximal course?. Circulation 1995, 92:3163-3171.
9. Mavrogeni S., Papadopoulos G., Douskou M., Kaklis S., Seimenis I., Baras I., et al. Magnetic resonance angiography is equivalent to x-ray coronary angiography for the evaluation of the coronary arteries in Kawasaki disease. J Am Coll Cardiol 2004, 43:649-652.
10. Mavrogeni S., Manginas A., Papadakis E., Foussas S., Douskou M., Baras P., et al. Correlation between magnetic resonance angiography (MRA) and quantitative coronary angiography (QCA) in ectatic coronary vessels. J Cardiovasc Magn Reson 2006, 8:493-498.
11. Mavrogeni S., Manoussakis M.N., Karagiorga T.C., Douskou M., Panagiotakos D., Bournia V., et al. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum 2009, 61:1121-1129.
12. Kwong R.Y., Chan A.K., Brown K.A., Chan C.W., Reynolds H.G., Tsang S., et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113:2733-2743.
13. Mavrogeni S., Manoussakis M.N. Myocarditis and subclavian stenosis in Takayasu arteritis. Int J Cardiol 2009 May 29, [Epub ahead of print].
14. Schwitter J., Wacker C.M., van Rossum A.C., Lombardi M., Al-Saadi N., Ahlstrom H., et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008, 29:480-489.
15. Varghese A., Pennell D. Cardiovascular magnetic resonance made easy 2008, 16-19. Churchill Livingstone Elsevier, London, UK.
16. Scwitter J. CMR update 2008, 30-41. Switzerland. J. Schwitter (Ed.).
17. Schalla S., Nagel E., Lehmkuhl H., Klein C., Bornstedt A., Schnackenburg B., et al. Comparison of magnetic resonance real-time imaging of LV function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol 2001, 87:95-99.
18. Bottini P.B., Carr A.A., Prisant M., Flickinger F.W., Allison J.D., Gottdiener J.S. Magnetic resonance imaging compared to echocardiography to assess LV MASS in the hypertensive patient. Am J Hypertension 1995, 8:221-226.
19. Mavrogeni S., Spargias K., Markussis V., Kolovou G., Demerouti E., Papadopoulou E., et al. Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm Allergy Drug Targets 2009, 8:390-397.
20. Dennert R., Crijns H.J., Heymans S. Acute viral myocarditis. Eur Heart J 2008, 29:2073-2082.
21. Abdel-Aty H., Boye P., Zagrosek A., Wassmuth R., Kumar A., Messroghli D., et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005, 45:1815-1822.
22. Afonso L., Hari P., Pidlaoan V., Kondur A., Jacob S., Khetarpal V. Acute myocarditis: can novel echocardiographic techniques assist with diagnosis?. Eur J Echocardiogr 2010, 11:E5.
23. Kuhl U., Lauer B., Souvatzoglu M., Vosberg H., Schultheiss H.P. Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis: evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis. J Am Coll Cardiol 1998, 32:1371-1376.
24. Smedema J.P., van Paassen P., van Kroonenburgh M.J., Snoep G., Crijns H.J., Tervaert J.W. Cardiac involvement of Churg Strauss syndrome demonstrated by magnetic resonance imaging. Clin Exp Rheumatol 2004, 22:S75-S78.
25. Neumann T., Manger B., Schmid M., Kroegel C., Hansch A., Kaiser W.A., et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) 2009, 88:236-243.
26. Mavrogeni S., Tsirogianni A.K., Gialafos E.J., Manoussakis M.N. Detection of myocardial inflammation by contrast-enhanced MRI in a patient with Churg-Strauss syndrome. Int J Cardiol 2009, 131:e54-e55.
27. Vignaux O., Marmursztejn J., Cohen P., Bruguière E., Duboc D., Guillevin L., et al. Cardiac imaging in ANCA-associated vasculitis. Presse Med 2007, 36:902-906.
28. Ohata S., Shimada T., Shimizu H., Murakami Y., Matsuno Y. Myocarditis associated with polymyositis diagnosed by gadolinium-DTPA enhanced magnetic resonance imaging. J Rheumatol 2002, 29:861-862.
29. Allanore Y., Vignaux O., Arnaud L., Puéchal X., Pavy S., Duboc D., et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 2006, 65:249-252.
30. Been M., Thomson B.J., Smith M.A., Ridgway J.P., Douglas R.H., Been M., et al. Myocardial involvement in systemic lupus erythematosus detected by magnetic resonance imaging. Eur Heart J 1988, 9:1250-1256.
31. Singh J.A., Woodard P.K., Dávila-Román V.G., Waggoner A.D., Gutierrez F.R., Zheng J., et al. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus 2005, 14:137-144.
32. Dennert R.M., van Paassen P., Schalla S., Kuznetsova T., Alzand B.S., Staessen J.A., et al. Cardiac involvement in Churg-Strauss syndrome. Arthritis Rheum 2010, 62:627-634.
33. Cheong B.Y., Muthupillai R., Nemeth M., Lambert B., Dees D., Huber S., et al. The utility of delayed-enhancement magnetic resonance imaging for identifying non-ischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2009, 26:39-46.
34. Nagel E., Lehmkuh H.B., Bocksch W., Klein C., Vogel U., Frantz E., et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999, 99:763-770.
35. Wahl A., Paetsch I., Roethemeyer S., Klein C., Fleck E., Nagel E. High-dose dobutamine-atropine stress cardiovascular magnetic resonance for follow-up after coronary revascularization procedures in patients with wall motion abnormalities at rest. Radiology 2004, 233:210-216.
36. Hundley W.G., Hamilton C.A., Thomas M.S., Herrington D.M., Salido T.B., Kitzman D.W., et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999, 100:1697-1702.
37. Danias P.G. Gadolinium-enhanced cardiac magnetic resonance imaging: expanding the spectrum of clinical applications. Am J Med 2001, 110:591-592.
38. Schwitter J. Myocardial perfusion imaging by cardiac magnetic resonance. J Nucl Cardiol 2006, 13:841-854.
39. Schwitter J., Nanz D., Kneifel S., Bertschinger K., Buchi M., Knusel P.R., et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001, 103:2230-2235.
40. Plein S., Ryf S., Schwitter J., Radjenovic A., Boesiger P., Kozerke S. Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med 2007, 58:777-785.
41. Gebker R., Jahnke C., Paetsch I., Kelle S., Schnackenburg B., Fleck E., et al. Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease. Radiology 2008, 247:57-63.
42. Cheng A.S., Pegg T.J., Karamitsos T.D., Searle N., Jerosch-Herold M., Choudhury R.P., et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol 2007, 49:2440-2449.
43. Fritz-Hansen T., Hove J.D., Kofoed K.F., Kelbaek H., Larsson H.B. Quantification of MRI measured myocardial perfusion reserve in healthy humans: a comparison with positron emission tomography. J Magn Reson Imaging 2008, 27:818-824.
44. Jerosch-Herold M., Wilke N., Stillman A.E. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998, 25:73-84.
45. Selvanayagam J.B., Jerosch-Herold M., Porto I., Sheridan D., Cheng A.S., Petersen S.E., et al. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation 2005, 112:3289-3296.
46. Nagel E., Klein C., Paetsch I., Hettwer S., Schnackenburg B., Wegscheider K., et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003, 108:432-437.
47. Cullen J.H., Horsfield M.A., Reek C.R., Cherryman G.R., Barnett D.B., Samani N.J. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 1999, 33:1386-1394.
48. Al-Saadi N., Nagel E., Gross M., Bornstedt A., Schnackenburg B., Klein C., et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000, 101:1379-1383.
49. Wolff S.D., Schwitter J., Coulden R., Friedrich M.G., Bluemke D.A., Biederman R.W., et al. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation 2004, 110:732-737.
50. Bruce I.N., Burns R.J., Gladman D.D., Urowitz M.B. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. J Rheumatol 2000, 27:2372-2377.
51. Bruce I.N., Gladman D.D., Ibañez D., Urowitz M.B. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities. J Rheumatol 2003, 30:288-291.
52. Nikpour M., Gladman D.D., Ibañez D., Bruce I.N., Burns R.J., Urowitz M.B. Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus. J Rheumatol 2009, 36:288-294.
53. Vignaux O., Allanore Y., Meune C., Pascal O., Duboc D., Weber S., et al. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis. Ann Rheum Dis 2005, 64:1268-1273.
54. Kobayashi H., Yokoe I., Hirano M., Nakamura T., Nakajima Y., Fontaine K.R., et al. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 2009, 36:106-112.
55. Kim R.J., Chen E.L., Lima J.A., Judd R.M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996, 94:3318-3326.
56. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
57. Judd R.M., Lugo-Olivieri C.H., Arai M., Kondo T., Croisille P., Lima J.A., et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995, 92:1902-1910.
58. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
59. Fieno D.S., Kim R.J., Chen E.L., Lomasney J.W., Klocke F.J., Judd R.M. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000, 36:1985-1991.
60. Wu E., Judd R.M., Vargas J.D., Klocke F.J., Bonow R.O., Kim R.J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001, 357:21-28.
61. Kaandorp T.A., Lamb H.J., Poldermans D., Viergever E.P., Boersma E., van der Wall E.E., et al. Assessment of right ventricular infarction with contrast-enhanced magnetic resonance imaging. Coron Artery Dis 2007, 18:39-43.
62. Kumar A., Abdel-Aty H., Kriedemann I., Schulz-Menger J., Gross C.M., Dietz R., et al. Contrast enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol 2006, 48:1969-1976.
63. Larose E., Ganz P., Reynolds H.G., Dorbala S., Di Carli M.F., Brown K.A., et al. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 2007, 49:855-862.
64. Roes S.D., Kelle S., Kaandorp T.A., Kokocinski T., Poldermans D., Lamb H.J., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002, 105:162-167.
65. Wagner A., Mahrholdt H., Holly T.A., Elliott M.D., Regenfus M., Parker M., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003, 361:374-379.
66. Bondarenko O., Beek A.M., Nijveldt R., McCann G.P., van Dockum W.G., Hofman M.B., et al. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis. J Cardiovasc Magn Reson 2007, 9:815-821.
67. Mavrogeni S., Papadopoulos G., Douskou M., Kaklis S., Seimenis I., Varlamis G., et al. Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. J Cardiovasc Magn Reson 2006, 8:493-498.
68. Plastiras S.C., Tzelepis G.E., Kelekis N.L., Vlachoyiannopoulos P.G. Catastrophic antiphospholipid syndrome with heart involvement: diagnostic utility of the cardiac MRI. Int J Cardiol 2007, 116:e29-e31.
69. Nobrega T.P., Klodas E., Breen J.F., Liggett S.P., Higano S.T., Reeder G.S. Giant coronary artery aneurysms and myocardial infarction in a patient with systemic lupus erythematosus. Cathet Cardiovasc Diagn 1996, 39:75-79.
70. Abdel-Aty H., Zagrosek A., Schulz-Menger J., Taylor A.J., Messroghli D., Kumar A., et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004, 109:2411-2416.
71. Kellman P., Aletras A.H., Mancini C., McVeigh E.R., Arai A.E. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med 2007, 57:891-897.
72. Wassmuth R., Göbel U., Natusch A., Schneider W., Kettritz R., Dietz R., et al. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J Card Fail 2008, 14:856-860.
73. Abdel-Aty H., Siegle N., Natusch A., Gromnica-Ihle E., Wassmuth R., Dietz R., et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus 2008, 17:561-567.
74. Singh J.A., Woodard P.K., Dávila-Román V.G., Waggoner A.D., Gutierrez F.R., Zheng J., et al. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus 2005, 14(2):137-144.
75. Jahnke C., Paetsch I., Nehrke K., Schnackenburg B., Gebker R., Fleck E., et al. Rapid and complete coronary arterial tree visualization with magnetic resonance imaging: feasibility and diagnostic performance. Eur Heart J 2005, 26:2313-2319.
76. Sakuma H., Ichikawa Y., Suzawa N., Hirano T., Makino T., Takeda K. Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 2006, 48:1946-1950.
77. Greil G.F., Seeger A., Miller S., Claussen C.D., Hofbeck M., Botnar R.M., et al. Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease. Pediatr Radiol 2007, 37:666-673.
78. Takemura A., Suzuki A., Inaba R., Sonobe T., Tsuchiya K., Omuro M., et al. Utility of coronary MR angiography in children with Kawasaki disease. AJR Am J Roentgenol 2007, 188:W534-W539.
79. Greil G.F., Stuber M., Botnar R.M., Kissinger K.V., Geva T., Newburger J.W., et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 2002, 105:908-911.
80. Kaku Y., Hamada J.I., Kuroda J.I., Kai Y., Morioka M., Kuratsu J.I. Multiple peripheral middle cerebral artery aneurysms associated with Behcet's disease. Acta Neurochir 2007, 149(8):823-827.
81. Emad Y., Ragab Y., Shawki Ael-H., Gheita T., El-Marakbi A., Salama M.H. Hughes-Stovin syndrome: is it incomplete Behçet's?. Report of two cases and review of the literature. Clin Rheumatol 2007, 26(11):1993-1996.
82. Zimmer S., Nickenig G. Pulselessness in the upper extremities: Takayasu arteritis. J Am Coll Cardiol 2009, 54:660.
83. Bartels A.L., Zeebregts C.J., Bijl M., Tio R.A., Slart R.H. Fused FDG-PET and MRI imaging of Takayasu arteritis in vertebral arteries. Ann Nucl Med 2009, 23(8):753-756.
84. Keenan N.G., Mason J.C., Maceira A., Assomull R., O'Hanlon R., Chan C., et al. Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. Arthritis Rheum 2009, 60:3501-3509.
85. Lin J., Chen B., Wang J.H., Zeng M.S., Wang Y.X. Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multi-channel MR system for the detection of various systemic arterial diseases. Heart Vessels 2006, 21(6):395-398.
86. Zhao H., Yuan Y., Li Y., Si C.W., Tian G.S., Wang G.Q., et al. Encephalic large arteries narrowness and peripheral neuropathy in a patient with adult-onset Still's disease. Rheumatol Int 2008, 28:1261-1264.